Joseph Flanagan Joins Accretive Health as Chief Operating Officer

Accretive Health (NYSE: AH ) announced today the appointment of Joseph Flanagan as its new chief operating officer. In this role, Mr. Flanagan will report to president and chief executive officer Stephen Schuckenbrock and be responsible for delivering exceptional operational discipline and client value creation throughout the company's operations.